Adverse events during treatment with recombinant insulin-like growth factor I in patients with growth hormone insensitivity.
Ranke
M B
MB
Section of Paediatric Endocrinology, Children's Hospital, University of Tübingen, Germany.
Wilton
P
P
D002648:Child; D006130:Growth Disorders / Q000628:therapy; D013006:Growth Hormone / Q000172:deficiency / Q000502:physiology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects
D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone